Analysis Finds TrumpRx Drops Prices on Only 1 of 54 Drugs, Lawsuit Hits Pharma Giants

An analysis by the Center for American Progress revealed that TrumpRx, despite claims, offers genuinely lower prices on only one drug, Cetrotide, among 54 listed medications. This finding undermines assertions that the platform broadly lowers drug costs for uninsured Americans and highlights limitations in access and savings. Meanwhile, a U.S. appeals court revived a False Claims Act lawsuit accusing major drugmakers of overcharging the government under the 340B program, signaling intensified scrutiny over pharmaceutical pricing practices.